<DOC>
	<DOC>NCT00517322</DOC>
	<brief_summary>Aim of the study is to compare in hypertensive patients the effect of one year therapy with ACE-inhibitor (RAMIPRIL) or angiotensin II receptor blocker (IRBESARTAN) on left atrial remodelling and diastolic function.</brief_summary>
	<brief_title>Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Atrial Remodeling</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Irbesartan</mesh_term>
	<criteria>Â· mild to moderate essential hypertension no antihypertensive treatment good quality echocardiogram cardiovascular diseases (AMI, stroke o TIA) heart failure, valvular heart disease diabetes secondary hypertension atrial fibrillation hepatic and renal severe failure pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>left atrial volume</keyword>
	<keyword>hypertension</keyword>
	<keyword>ramipril</keyword>
	<keyword>irbesartan</keyword>
	<keyword>diastolic function</keyword>
</DOC>